SALIX PHARMACEUTICALS $66.42

down -0.41


19/6/2013 04:19 PM  |  NASDAQ : SLXP  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get SLXP Trend Analysis - it has outperformed the S&P 500 by 3%

ETF Alternatives



People viewing SLXP also viewed: , , , ,

Competitors

Ticker Name Volume % Change
ACEL TAMIR BIOTECHNOLOGY 5.5K +1.50%
WPHM WINSTON PHARMACEUTICALS 20.0K +1.50%
CKGT CHINA KANGTAI CACTUS BIO 500.0 +1.11%
MLGGY MELDEX INTERNATIONAL 300.0 +1.00%
PARS PHARMOS 3.2K +0.73%
View All

SLXP Stock Analysis

  1.

    MediciNova Presents MN-166 Data - Analyst Blog

    (MNOV,SNTS,TEVA,SLXP )
    MediciNova announced the presentation of preliminary data from a phase Ib study of MN-166 for the treatment of methamphetamine addiction
  2.

    Valeant Raising Funds - Analyst Blog

    (VRX,SNTS,SLXP,JAZZ )
    Valeant Pharmaceuticals recently announced its intention to raise funds through the issuance of common shares.

  3. ViroPharma Up on Takeover Rumors - Analyst Blog

    (VPHM,SNTS,SLXP,JAZZ )
    As per Reuters, several pharmaceutical companies have shown an interest in acquiring ViroPharma given the company's orphan disease drug portfolio.

  4. AstraZeneca and NGM Collaborate - Analyst Blog

    (SNTS,AZN,SLXP,OMTH )
    AstraZeneca entered into an agreement with NGM Biopharmaceuticals, Inc. to develop candidates for type II diabetes and obesity.
  5.

    US Launch of Forest's Namenda XR - Analyst Blog

    (FRX,SNTS,SLXP,JAZZ )
    Namenda XR is a once-daily extended-release version of the company's immediate release formulation of Namenda.

  6. XOMA Commences Gevokizumab Study - Analyst Blog

    (SNTS,XOMA,SLXP,JAZZ )
    XOMA Corporation announced the initiation of a pilot study to evaluate the use of gevokizumab in acute inflammatory pyoderma gangrenosum patients
  7.

    Update on UCB Lupus Candidate - Analyst Blog

    (UCBJF,IMMU,SLXP,TKPYY )
    UCB recently presented new data on its lupus candidate, epratuzumab, from an open-label extension study of the EMBLEM phase IIb study

  8. FDA Panel Meeting for Salix Drug - Analyst Blog

    (PGNX,SLXP,SNTS,JAZZ )
    The FDA's advisory panel will review Salix' supplemental new drug application for Relistor for opioid-induced constipation in patients with chronic pain.
Free Reports
  1.

    Trading Systems at No Cost

    Get a FREE Magazine on the Top 10 Trading Systems.
  2.

    5 Key Factors That Move The Currency Market

    Take Advantage of Boris Schlossberg & Kathy Lien’s Expertise, and Start Profiting Today!
  3.

    Get 4 quotes FREE - Refinance and Save

    Instant matching service with top lenders.
Marketplace
Trading Center